US20120329164A1 - Test Unit Cartridge for Analyte Testing Device - Google Patents

Test Unit Cartridge for Analyte Testing Device Download PDF

Info

Publication number
US20120329164A1
US20120329164A1 US13/308,137 US201113308137A US2012329164A1 US 20120329164 A1 US20120329164 A1 US 20120329164A1 US 201113308137 A US201113308137 A US 201113308137A US 2012329164 A1 US2012329164 A1 US 2012329164A1
Authority
US
United States
Prior art keywords
cartridge
test unit
analyte
test
units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US13/308,137
Other versions
US8333717B1 (en
Inventor
Gad Shaanan
Marc Goldman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YOFIMETER LLC
Original Assignee
GADLIGHT Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/165,621 external-priority patent/US20120330119A1/en
Assigned to GADLIGHT, INC. reassignment GADLIGHT, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOLDMAN, MARC, SHAANAN, GAD
Priority to US13/308,137 priority Critical patent/US8333717B1/en
Application filed by GADLIGHT Inc filed Critical GADLIGHT Inc
Assigned to YofiMETER, Inc. reassignment YofiMETER, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GADLIGHT, INC.
Priority to PCT/US2012/043588 priority patent/WO2012177908A1/en
Priority to EP12743557.6A priority patent/EP2723235B1/en
Priority to CA2839900A priority patent/CA2839900A1/en
Priority to JP2014517176A priority patent/JP5998212B2/en
Priority to KR1020147001534A priority patent/KR101596799B1/en
Assigned to YOFIMETER, LLC reassignment YOFIMETER, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S BUSINESS ENTITY DESIGNATION FROM "INC." TO "LLC" PREVIOUSLY RECORDED ON REEL 028080 FRAME 0570. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE'S CORRECT BUSINESS NAME AND ENTITY IS YOFIMETER, LLC. Assignors: GADLIGHT, INC.
Publication of US8333717B1 publication Critical patent/US8333717B1/en
Application granted granted Critical
Publication of US20120329164A1 publication Critical patent/US20120329164A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150267Modular design or construction, i.e. subunits are assembled separately before being joined together or the device comprises interchangeable or detachable modules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150358Strips for collecting blood, e.g. absorbent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150503Single-ended needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150534Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
    • A61B5/150572Pierceable protectors, e.g. shields, caps, sleeves or films, e.g. for hygienic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15107Piercing being assisted by a triggering mechanism
    • A61B5/15113Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15115Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15117Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising biased elements, resilient elements or a spring, e.g. a helical spring, leaf spring, or elastic strap
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15148Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
    • A61B5/15149Arrangement of piercing elements relative to each other
    • A61B5/15153Multiple piercing elements stocked in a single compartment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15148Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
    • A61B5/15157Geometry of stocking means or arrangement of piercing elements therein
    • A61B5/15174Piercing elements stocked in the form of a stack or pile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/157Devices characterised by integrated means for measuring characteristics of blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/4875Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
    • G01N33/48757Test elements dispensed from a stack
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0295Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Definitions

  • the field of the invention is analyte testing supplies, more specifically, test unit cartridges.
  • Analyte testing devices play a critical roll in modern diagnosis and management of health-related issues.
  • a sample of human blood, urine, and/or saliva can be tested for glucose, fructosamine, hematocrit, hemoglobin blood oxygen saturation, lactates, iron, pH, cholesterol, liver enzymes (AST, ALT, alkaline phosphatase/GGT, LDH, bilirubin, etc), hormones, and other compounds.
  • monitoring glucose levels is inconvenient and uncomfortable, since it requires repeatedly pricking the finger or some other body member in order to draw a blood sample. It would be advantageous to maximize the utility of a blood sample by collecting more than one kind of health data using the same meter, and even more preferably from the same “stick”. For example, while a diabetes patient is primarily concerned with monitoring glucose levels, it would be advantageous for diabetic patients to simultaneously, or in close time proximity, collect pH, iron, fructosamine or other health data. Such additional health data can be used as a baseline for later medical reference, or alternatively, for proactively monitoring for other potential health problems.
  • test unit referred to as a cassette
  • two test spots i.e., two analyte sensors.
  • One is for measuring glycated albumin
  • the other is for measuring total albumin (for diabetes management).
  • Smith still does not contemplate a cassette that carries two or more different types of test units (i.e., non-fungible test units).
  • test unit that tests for two or more analytes
  • known prior art has failed to provide a cartridge for holding a plurality of test units, wherein at least two of the test units are non-fungible (e.g., a first test unit configured to detect a first analyte and a second test unit configured to test a second analyte that is different from the first analyte). It would therefore be advantageous to provide a cartridge that includes different test units for detecting different analytes.
  • an inventive cartridge holding twenty separate test units could include glucose-detecting analyte sensors on every test unit, and fructosamine-detecting analyte sensors on every fifth test unit (i.e., every fifth test unit has two analyte sensors). Furthermore, it would be advantageous for that device to automatically store and monitor both glucose and fructosamine levels. In this manner, a diabetic patient primarily concerned with glucose levels could simultaneously collect other important health data, thus maximizing the utility of each blood sample.
  • test unit cartridges that include non-fungible test units.
  • test unit cartridge houses: (i) a first test unit having a first analyte sensor that includes a first reagent used to detect a first analyte; and (ii) a second test unit having a second analyte sensor that includes a second reagent used to detect a second analyte different from the first analyte, such that the first test unit is not functionally fungible with the second test unit.
  • the test unit comprises a single strip.
  • strip means a thin (less than 5 mm thick) elongated object having at least one analyte sensor.
  • a test unit can also comprise a non-strip configuration, such as a capsule more that 5 mm thick, or a disk.
  • the first test unit has no other analyte sensors besides the first analyte sensor.
  • the first test unit can include an additional analyte senor that detects the second analyte.
  • the cartridge includes a “sacrificial” test unit disposed at a beginning of an order of use of the cartridge.
  • the sacrificial test unit is configured to provide a moisture barrier by corking and sealing all apertures of the cartridge.
  • the “sacrificial” test unit can optionally include at least two analyte sensors for detecting multiple analytes. It is also contemplated that each test unit can include features that cork the apertures of the cartridge such that the test units are protected from moisture and dust when not in use.
  • the test unit cartridge includes a third through twentieth test unit, each of which is functionally fungible with the first test unit.
  • the first reagent and second reagent are different.
  • the first reagent is configured to bind with a first analyte and the second reagent is configured to bind with a second analyte.
  • the cartridge includes pull-away labels that cover every aperture of the cartridge in order to provide a seal and barrier from moisture and dust.
  • the cartridge includes an aperture that allows an electrical contact of the first test unit to directly couple with an electrical contact of an analyte testing device.
  • the inventive subject matter also provides apparatus, systems, and methods in which a test unit cartridge has a plurality of test units, wherein at least one of the test units has a first and second analyte sensor configured to detect a first and second analyte, respectively.
  • the first and second analyte sensors can be completely non-overlapping, partly overlapping, or completely overlapping. In some aspects of preferred embodiments, the first and second analyte sensors are physically separated by a distance.
  • a test unit cartridge includes a calibration test unit and an operating test unit.
  • calibration test unit means a test unit having a known analyte presence and configured to test the accuracy of an analyte testing device (e.g., glucose meter).
  • operating test unit means a test unit having an analyte sensor that is configured to detect an analyte.
  • the inventive subject matter also provides apparatus, systems, and methods in which a test unit cartridge has a plurality of test units and a spring.
  • the spring is disposed in a manner such that each test unit is advanced into a usable position after a previous test strip has been laterally ejected from the cartridge.
  • the inventive subject matter also provides apparatus, systems, and methods in which a test unit cartridge houses a plurality of test units in a stacked configuration.
  • an analyte testing device can be used by: (i) inserting a lancet cartridge into the device; (ii) inserting a test unit cartridge into the device, wherein the test unit cartridge has a plurality of nonfungible test units; (iii) operating a mechanically advantaged actuator on the device, which operates a mechanism that (a) readies a lancing device, (b) exposes an analyte sensor of a test unit, and (c) advances the lancet cartridge; (iv) deploying the lancing device in order to prick a body part and draw a blood sample; and (v) contacting the analyte sensor to the blood sample.
  • Preferred methods further include reading an output of the device; ejecting and disposing of the test unit; replacing the lancet cartridge with a refill lancet cartridge; and replacing the test unit cartridge with a refill test unit cartridge.
  • the nonfungible test units preferably comprise at least one test unit configured to detect a first and second analyte.
  • FIG. 1 is a perspective view of one embodiment of a test unit cartridge for housing a plurality of test units.
  • FIG. 2 is a side view of the test unit cartridge of FIG. 1 .
  • FIG. 3 is a perspective view of one embodiment of a test unit.
  • FIG. 4 is a perspective view of another embodiment of a test unit.
  • FIG. 5 is a perspective view of a calibration test unit.
  • FIG. 6 is a perspective view of one embedment of an analyte testing device.
  • FIG. 7 is a schematic of one embodiment of a method of using the test unit cartridge of FIG. 1 .
  • inventive subject matter is considered to include all possible combinations of the disclosed elements.
  • inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
  • FIGS. 1 and 2 show perspective and side views, respectively, of a test unit cartridge 100 .
  • Cartridge 100 holds a plurality of test units 110 in a stacked configuration.
  • the stacked configuration of test units 110 advantageously allows cartridge 100 to have a compact and simple design that requires minimal material.
  • Cartridge 100 is configured to couple with an analyte testing device.
  • cartridge 100 has electrical contacts 128 for communicatively coupling the test units 110 with conversion electronics in an analyte testing device.
  • Cartridge 100 also has a slot 129 that couples with a linkage mechanism of an analyte device, wherein the linkage is configured to push a portion of a test unit out of cartridge 100 in order to expose analyte sensor 115 .
  • Cartridge 100 is preferably sized and dimensioned to mate with a compartment of an analyte testing device.
  • Cartridge 100 can include any appropriate number of test units, preferably between 15 and 25 test units, more preferably between 18 and 22 test units, and most preferably 20 test units. Cartridge 100 includes test units configured to test for different analytes.
  • test unit 110 a has an analyte sensor 115 a, which includes an analyte-binding reagent configured to test for glucose.
  • Test unit 110 b has two analyte sensors (sensor 115 b and sensor 116 b ) for detecting two different analytes (e.g., glucose and iron) using only one fluid sample.
  • Cartridge 100 also has a calibration test unit 110 c that has two analyte sensors: sensor 115 c is for detecting glucose and calibration sensor 116 c is for checking the accuracy of an analyte meter.
  • Cartridge 100 can include a test unit that is functionally fungible with 110 b or 110 c at every n th test unit within the plurality of test units 110 in order to ensure that certain health data is gathered at particular intervals.
  • cartridge 100 holds twenty test units, wherein the first and third through twentieth test units are configured to detect glucose, and the second test unit is configured to detect glucose and fructosamine. In this manner, fructosamine levels are monitored at every second test unit of every test unit cartridge.
  • the housing of cartridge 100 can be made of plastic, metal, composite, or any other material with structural and mechanical properties suitable for housing a plurality of test units.
  • Cartridge 100 is preferably compact, with a height no more than 25 mm, a width no more than 15 mm, and a length no more than 50 mm. In especially preferred embodiments, the height is no more than 20 mm, a width is no more than 8 mm, and a length is no more than 40 mm.
  • Cartridge 100 also preferably includes an inner desiccant liner (not shown) for protecting the plurality of test units from exposure to moisture.
  • a liner can be disposed between the test units and the inner wall of cartridge 100 , thus surrounding all the test units (e.g., an inner sleeve).
  • the liner comprises a crystalline structure configured to absorb moisture and prevent moisture from reaching the analyte sensors. Liners are well known and all materials suitable for absorbing and/or blocking moisture are contemplated.
  • all cartridge apertures are preferably sealed with a pull-away adhesive label. For example, pull-away label 131 has been placed over slot 129 in order to seal slot 129 , thus protecting test units 110 from exposure to moisture and dust.
  • slot 132 , slot 133 and all other orifices/apertures of cartridge 100 are sealed with a pull-away label.
  • the labels can be removed just prior to loading cartridge 100 into device 600 (see FIG. 6 ).
  • Cartridge 100 also preferably includes gaskets and/or o-rings at all cartridge apertures. These gaskets can be configured to mate with components of device 600 such that a seal is maintained while cartridge 100 is loaded in device 600 and not in use.
  • Cartridge 100 also includes a spring 175 , which is disposed below the plurality of test units 110 and is configured to push the test units 110 upward. In this manner, each test unit is pushed up into a usable position after the previous test unit is laterally ejected out of slot 132 .
  • Cartridge 100 provides several advantages. First, by providing a plurality of test units in one disposable and replaceable cartridge, methods and devices for monitoring analytes is significantly simplified. Second, cartridge 100 provides a means for ensuring that secondary health data is gathered at predetermined intervals. For example, a diabetes patient monitoring glucose levels (i.e., primary health data) will nonetheless monitor secondary health data (e.g., fructasomine levels) when test unit 110 b is used. Third, cartridge 100 allows primary and secondary health data to be gathered simultaneously in a single blood sample. Fourth, cartridge 100 provides an enclosure that protects a plurality of test units from exposure to moisture and dust. Finally, cartridge 100 provides a simple mechanism for advancing each test unit into place after the previous test unit has been removed and disposed.
  • primary health data i.e., primary health data
  • secondary health data e.g., fructasomine levels
  • FIG. 3 shows a test unit 110 a, which has an analyte sensor 115 a.
  • Analyte sensors are well known and generally comprise an absorbent material that includes a reagent (e.g., an analyte-binding reagent).
  • sensor 115 a is configured to detect glucose.
  • the sensor 115 a is configured to generate a signal that is sent to electrical contacts 130 .
  • Electrical contacts 130 are communicatively coupled with electrical contacts 128 of cartridge 100 , thus allowing the signal to reach conversion electronics in an analyte testing device (e.g., a glucose meter).
  • an analyte testing device e.g., a glucose meter
  • test unit 110 a allows a diabetic patient to monitor glucose levels.
  • analyte sensor refers to an independently interpretable signal representing an amount of an analyte present in a fluid sample.
  • one piece of absorbent material having one reagent that is capable of binding to two different analytes at the same time would be considered two separate “analyte sensors” if two independently interpretable signals are produced, regardless of whether the signal is interpreted using two different lead wires or using one lead wire (e.g., one signal having two frequency spikes that represent the amount of two different analytes present in the fluid sample).
  • Test unit 110 a also advantageously includes a first sealing surface 134 and a second sealing surface 135 , configured to restrict entry of moisture into the interior of cartridge 100 via slots 132 and 133 , respectively.
  • Test unit 110 a is disposed at the beginning of the order of use of the plurality of test units 110 in cartridge 100 (i.e., on top of the stack of test units 110 , see FIG. 1 ). As such, test unit 110 a serves to protect the plurality of test units 110 from damage caused by moisture and dust.
  • Test unit 110 a can either be a “sacrificial unit,” meaning its sole purpose is to provide a cork/seal to the orifices of cartridge 100 , or can optionally include analyte sensors, such as analyte sensor 115 a.
  • Test unit 110 a also preferably includes a sealing surface on its back side to provide a seal at slot 129 . It is also contemplated that each of the plurality of test units 110 can include sealing surfaces to protect each subsequent test unit from moisture.
  • test unit 110 a having a “strip” configuration
  • test unit 110 a could comprise a capsule or a disk rather than a strip.
  • stackable test units are preferred in order to conserve space.
  • FIG. 4 shows a test unit 110 b, which has two analyte sensors 115 b and 116 b. Sensor 115 b is configured to detect glucose, while sensor 116 b is configured to detect fructosamine. Test unit 110 b advantageously provides a means for testing for two analytes using one blood sample (i.e., from a single prick and a single test unit). While FIG. 4 shows sensors 115 b and 116 b in completely non-overlapping positions, it is also contemplated that sensors 115 b and 116 b could be partially overlapping, or even completely overlapping.
  • sensors 115 b and 116 b could comprise one absorbent material and one analyte-binding reagent, wherein the analyte-binding reagent is capable of simultaneously binding with two or more analytes and can produce two “distinct” signals (e.g., one signal with two different detectible frequency spikes, or two different signals representing two distinct analytes).
  • the analyte-binding reagent is capable of simultaneously binding with two or more analytes and can produce two “distinct” signals (e.g., one signal with two different detectible frequency spikes, or two different signals representing two distinct analytes).
  • additional sensors can be included on test unit 110 b for detecting additional analytes.
  • Test unit 110 a and test unit 110 b are “functionally nonfungible” since unit 110 a tests for glucose while unit 110 b detects glucose and fructosamine.
  • An example of two functionally fungible test units is a first test unit that test for glucose and iron, and a second test unit that tests for glucose and iron.
  • FIG. 5 shows a test unit 110 c, which has two analyte sensors 115 c and 116 c.
  • Sensor 115 c is configured to detect glucose
  • calibration sensor 116 c is configured to check the accuracy of an analyte testing device.
  • sensor 115 c is an “operational sensor”
  • sensor 116 c is a “calibration sensor.”
  • Sensor 116 c has a known concentration of a particular analyte and produces a signal that is expected to result in a known reading on device 600 . In this manner, the electronics of device 600 can be checked for accuracy, precision, and consistency.
  • FIG. 6 shows an analyte testing device 600 .
  • Device 600 is a glucose meter integrated with a lancing device.
  • Device 600 has an actuator 620 and an internal linkage mechanism (not shown) configured to cock a lancet for drawing blood, partially expose a test unit for contacting with a blood sample, and reading a signal of the test unit.
  • Device 600 also has an internal compartment 610 for loading and storing cartridge 100 .
  • Device 600 also preferably has an internal compartment for storing a cartridge of lancets (not shown).
  • One exemplary embodiment of a glucose meter is disclosed in U.S. patent application Ser. No. 13/165,621, which is incorporated herein by reference.
  • Device 600 can further include a docking station and data management software.
  • a docking station and data management software Acceptable docking stations and data management systems that could be adapted for use within the existing subject matter is described in co-pending patent application having Ser. No. 13/187,360 titled to Shaanan et al. “Analyte Testing System With Docking Station For Data Management” filed on Jul. 20, 2011.
  • FIG. 7 shows a method of using test cartridge 100 and analyte testing device 600 , comprising: inserting a lancet cartridge into the device; inserting a test unit cartridge into the device, wherein the test unit cartridge has a plurality of nonfungible test units; operating an actuator on the device, which operates a mechanism that (i) readies a lancing device, (ii) advances the lancet cartridge, and (iii) exposes an analyte sensor of a test unit; deploying the lancing device in order to prick a body part and draw a blood sample; and exposing the analyte sensor to the blood sample; reading an output of the device; ejecting and disposing of the test unit; replacing the lancet cartridge with a refill lancet cartridge; and replacing the test unit cartridge with a refill test unit cartridge.
  • the nonfungible test units preferably comprise at least one test unit configured to detect a first and second analyte.
  • the actuator is mechanically advantaged and the step of operating the actuator comprises cocking a lever.
  • Coupled to is intended to include both direct coupling (in which two elements that are coupled to each other contact each other) and indirect coupling (in which at least one additional element is located between the two elements). Therefore, the terms “coupled to” and “coupled with” are used synonymously.

Abstract

A test unit cartridge for holding a plurality of test units includes a first test unit that contains a first analyte sensor and a second test unit that contains a second analyte sensor. The first and second analyte sensors use first and second reagents to detect first and second analytes, respectively. The first analyte is different from the second analyte and the first and second test units are functionally non-fungible. The plurality of test units can also include a third test unit that contains two analyte sensors having two reagents for detecting two different analytes using one fluid sample. A method of using the test unit cartridge is also described, which comprises loading the cartridge into an analyte testing device and cocking an actuator of the device that is configured to (i) expose an analyte sensor of a test unit, (ii) ready a lancet, and (iii) advance a lancet cartridge.

Description

  • This application is a continuation of U.S. patent application Ser. No. 13/187,397 filed Jul. 20, 2011, which is a continuation-in-part of U.S. patent application Ser. No. 13/165,621 filed Jun. 21, 2011, which are incorporated herein by reference in its entirety.
  • FIELD OF THE INVENTION
  • The field of the invention is analyte testing supplies, more specifically, test unit cartridges.
  • BACKGROUND
  • Analyte testing devices play a critical roll in modern diagnosis and management of health-related issues. For example, a sample of human blood, urine, and/or saliva can be tested for glucose, fructosamine, hematocrit, hemoglobin blood oxygen saturation, lactates, iron, pH, cholesterol, liver enzymes (AST, ALT, alkaline phosphatase/GGT, LDH, bilirubin, etc), hormones, and other compounds.
  • For many diabetic patients, monitoring glucose levels is inconvenient and uncomfortable, since it requires repeatedly pricking the finger or some other body member in order to draw a blood sample. It would be advantageous to maximize the utility of a blood sample by collecting more than one kind of health data using the same meter, and even more preferably from the same “stick”. For example, while a diabetes patient is primarily concerned with monitoring glucose levels, it would be advantageous for diabetic patients to simultaneously, or in close time proximity, collect pH, iron, fructosamine or other health data. Such additional health data can be used as a baseline for later medical reference, or alternatively, for proactively monitoring for other potential health problems.
  • Several known references are directed at a single test unit that simultaneously tests for two or more analytes. For example, each of U.S. Pat. 7,955,791 (Dinello), US20110124130 (Wagner), and US2010/0312137 (Gilmour) disclose test strips that test for two or more analytes using one strip. However, none of those references teach a cartridge (i.e., a magazine, cassette or other housing or enclosure) for holding two or more non-fungible test units.
  • US 2007/0007183 to Schulat discloses a magazine that holds a plurality of test units for measuring analytes like glucose. However, Schulat fails to contemplate that a magazine can hold test units that test for different analytes.
  • US 2010/0151488 to Smith discloses a test unit (referred to as a cassette) that has two test spots, i.e., two analyte sensors. One is for measuring glycated albumin, and the other is for measuring total albumin (for diabetes management). Smith, however, still does not contemplate a cassette that carries two or more different types of test units (i.e., non-fungible test units).
  • Thus, while known prior art has appreciated the advantages of a test unit that tests for two or more analytes, the known prior art has failed to provide a cartridge for holding a plurality of test units, wherein at least two of the test units are non-fungible (e.g., a first test unit configured to detect a first analyte and a second test unit configured to test a second analyte that is different from the first analyte). It would therefore be advantageous to provide a cartridge that includes different test units for detecting different analytes. For example, an inventive cartridge holding twenty separate test units could include glucose-detecting analyte sensors on every test unit, and fructosamine-detecting analyte sensors on every fifth test unit (i.e., every fifth test unit has two analyte sensors). Furthermore, it would be advantageous for that device to automatically store and monitor both glucose and fructosamine levels. In this manner, a diabetic patient primarily concerned with glucose levels could simultaneously collect other important health data, thus maximizing the utility of each blood sample.
  • Thus, there is still a need for test unit cartridges that include non-fungible test units.
  • SUMMARY OF THE INVENTION
  • The inventive subject matter provides apparatus, systems, and methods in which a test unit cartridge houses: (i) a first test unit having a first analyte sensor that includes a first reagent used to detect a first analyte; and (ii) a second test unit having a second analyte sensor that includes a second reagent used to detect a second analyte different from the first analyte, such that the first test unit is not functionally fungible with the second test unit.
  • In one aspect of some preferred embodiments, the test unit comprises a single strip. As used herein, the term “strip” means a thin (less than 5 mm thick) elongated object having at least one analyte sensor. A test unit can also comprise a non-strip configuration, such as a capsule more that 5 mm thick, or a disk.
  • In yet other aspects of preferred embodiments, the first test unit has no other analyte sensors besides the first analyte sensor. Alternatively, the first test unit can include an additional analyte senor that detects the second analyte.
  • In another aspect of some preferred embodiments, the cartridge includes a “sacrificial” test unit disposed at a beginning of an order of use of the cartridge. The sacrificial test unit is configured to provide a moisture barrier by corking and sealing all apertures of the cartridge. The “sacrificial” test unit can optionally include at least two analyte sensors for detecting multiple analytes. It is also contemplated that each test unit can include features that cork the apertures of the cartridge such that the test units are protected from moisture and dust when not in use.
  • In one aspect of preferred embodiments, the test unit cartridge includes a third through twentieth test unit, each of which is functionally fungible with the first test unit.
  • In yet other aspects of preferred embodiments, the first reagent and second reagent are different. For example, the first reagent is configured to bind with a first analyte and the second reagent is configured to bind with a second analyte.
  • In some aspects of preferred embodiments, the cartridge includes pull-away labels that cover every aperture of the cartridge in order to provide a seal and barrier from moisture and dust.
  • In yet other aspects, the cartridge includes an aperture that allows an electrical contact of the first test unit to directly couple with an electrical contact of an analyte testing device.
  • The inventive subject matter also provides apparatus, systems, and methods in which a test unit cartridge has a plurality of test units, wherein at least one of the test units has a first and second analyte sensor configured to detect a first and second analyte, respectively. The first and second analyte sensors can be completely non-overlapping, partly overlapping, or completely overlapping. In some aspects of preferred embodiments, the first and second analyte sensors are physically separated by a distance.
  • Yet still, the inventive subject matter provides apparatus, systems, and methods in which a test unit cartridge includes a calibration test unit and an operating test unit. As used herein, the term “calibration test unit” means a test unit having a known analyte presence and configured to test the accuracy of an analyte testing device (e.g., glucose meter). As used herein, the term “operating test unit” means a test unit having an analyte sensor that is configured to detect an analyte.
  • The inventive subject matter also provides apparatus, systems, and methods in which a test unit cartridge has a plurality of test units and a spring. The spring is disposed in a manner such that each test unit is advanced into a usable position after a previous test strip has been laterally ejected from the cartridge.
  • The inventive subject matter also provides apparatus, systems, and methods in which a test unit cartridge houses a plurality of test units in a stacked configuration.
  • From a method perspective, an analyte testing device can be used by: (i) inserting a lancet cartridge into the device; (ii) inserting a test unit cartridge into the device, wherein the test unit cartridge has a plurality of nonfungible test units; (iii) operating a mechanically advantaged actuator on the device, which operates a mechanism that (a) readies a lancing device, (b) exposes an analyte sensor of a test unit, and (c) advances the lancet cartridge; (iv) deploying the lancing device in order to prick a body part and draw a blood sample; and (v) contacting the analyte sensor to the blood sample.
  • Preferred methods further include reading an output of the device; ejecting and disposing of the test unit; replacing the lancet cartridge with a refill lancet cartridge; and replacing the test unit cartridge with a refill test unit cartridge. In addition, the nonfungible test units preferably comprise at least one test unit configured to detect a first and second analyte.
  • Various objects, features, aspects, and advantages of the inventive subject matter will become more apparent from the following detailed description of preferred embodiments, along with the accompanying drawing figures in which like numerals represent like components.
  • BRIEF DESCRIPTION OF THE DRAWING
  • FIG. 1 is a perspective view of one embodiment of a test unit cartridge for housing a plurality of test units.
  • FIG. 2 is a side view of the test unit cartridge of FIG. 1.
  • FIG. 3 is a perspective view of one embodiment of a test unit.
  • FIG. 4 is a perspective view of another embodiment of a test unit.
  • FIG. 5 is a perspective view of a calibration test unit.
  • FIG. 6 is a perspective view of one embedment of an analyte testing device.
  • FIG. 7 is a schematic of one embodiment of a method of using the test unit cartridge of FIG. 1.
  • DETAILED DESCRIPTION
  • The following discussion provides many example embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the disclosed elements. Thus if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
  • FIGS. 1 and 2 show perspective and side views, respectively, of a test unit cartridge 100. Cartridge 100 holds a plurality of test units 110 in a stacked configuration. The stacked configuration of test units 110 advantageously allows cartridge 100 to have a compact and simple design that requires minimal material. Cartridge 100 is configured to couple with an analyte testing device. For example, cartridge 100 has electrical contacts 128 for communicatively coupling the test units 110 with conversion electronics in an analyte testing device. Cartridge 100 also has a slot 129 that couples with a linkage mechanism of an analyte device, wherein the linkage is configured to push a portion of a test unit out of cartridge 100 in order to expose analyte sensor 115. Cartridge 100 is preferably sized and dimensioned to mate with a compartment of an analyte testing device.
  • Cartridge 100 can include any appropriate number of test units, preferably between 15 and 25 test units, more preferably between 18 and 22 test units, and most preferably 20 test units. Cartridge 100 includes test units configured to test for different analytes. For example, test unit 110 a has an analyte sensor 115 a, which includes an analyte-binding reagent configured to test for glucose. Test unit 110 b has two analyte sensors (sensor 115 b and sensor 116 b) for detecting two different analytes (e.g., glucose and iron) using only one fluid sample. Cartridge 100 also has a calibration test unit 110 c that has two analyte sensors: sensor 115 c is for detecting glucose and calibration sensor 116 c is for checking the accuracy of an analyte meter.
  • Unless the context dictates the contrary, all ranges set forth herein should be interpreted as being inclusive of their endpoints, and open-ended ranges should be interpreted to include commercially practical values. Similarly, all lists of values should be considered as inclusive of intermediate values unless the context indicates the contrary.
  • Cartridge 100 can include a test unit that is functionally fungible with 110 b or 110 c at every nth test unit within the plurality of test units 110 in order to ensure that certain health data is gathered at particular intervals. For example, in one preferred embodiment cartridge 100 holds twenty test units, wherein the first and third through twentieth test units are configured to detect glucose, and the second test unit is configured to detect glucose and fructosamine. In this manner, fructosamine levels are monitored at every second test unit of every test unit cartridge.
  • The housing of cartridge 100 can be made of plastic, metal, composite, or any other material with structural and mechanical properties suitable for housing a plurality of test units. Cartridge 100 is preferably compact, with a height no more than 25 mm, a width no more than 15 mm, and a length no more than 50 mm. In especially preferred embodiments, the height is no more than 20 mm, a width is no more than 8 mm, and a length is no more than 40 mm.
  • Cartridge 100 also preferably includes an inner desiccant liner (not shown) for protecting the plurality of test units from exposure to moisture. For example, a liner can be disposed between the test units and the inner wall of cartridge 100, thus surrounding all the test units (e.g., an inner sleeve). In some embodiments, the liner comprises a crystalline structure configured to absorb moisture and prevent moisture from reaching the analyte sensors. Liners are well known and all materials suitable for absorbing and/or blocking moisture are contemplated. In addition, all cartridge apertures are preferably sealed with a pull-away adhesive label. For example, pull-away label 131 has been placed over slot 129 in order to seal slot 129, thus protecting test units 110 from exposure to moisture and dust. Preferably, slot 132, slot 133 and all other orifices/apertures of cartridge 100 are sealed with a pull-away label. The labels can be removed just prior to loading cartridge 100 into device 600 (see FIG. 6). Cartridge 100 also preferably includes gaskets and/or o-rings at all cartridge apertures. These gaskets can be configured to mate with components of device 600 such that a seal is maintained while cartridge 100 is loaded in device 600 and not in use.
  • Cartridge 100 also includes a spring 175, which is disposed below the plurality of test units 110 and is configured to push the test units 110 upward. In this manner, each test unit is pushed up into a usable position after the previous test unit is laterally ejected out of slot 132.
  • Cartridge 100 provides several advantages. First, by providing a plurality of test units in one disposable and replaceable cartridge, methods and devices for monitoring analytes is significantly simplified. Second, cartridge 100 provides a means for ensuring that secondary health data is gathered at predetermined intervals. For example, a diabetes patient monitoring glucose levels (i.e., primary health data) will nonetheless monitor secondary health data (e.g., fructasomine levels) when test unit 110 b is used. Third, cartridge 100 allows primary and secondary health data to be gathered simultaneously in a single blood sample. Fourth, cartridge 100 provides an enclosure that protects a plurality of test units from exposure to moisture and dust. Finally, cartridge 100 provides a simple mechanism for advancing each test unit into place after the previous test unit has been removed and disposed.
  • FIG. 3 shows a test unit 110 a, which has an analyte sensor 115 a. Analyte sensors are well known and generally comprise an absorbent material that includes a reagent (e.g., an analyte-binding reagent). In this case, sensor 115 a is configured to detect glucose. The sensor 115 a is configured to generate a signal that is sent to electrical contacts 130. Electrical contacts 130 are communicatively coupled with electrical contacts 128 of cartridge 100, thus allowing the signal to reach conversion electronics in an analyte testing device (e.g., a glucose meter). Alternatively, electrical contacts 130 could directly interface with an analyte testing device's conversion electronics via an open aperture on cartridge 100 (e.g., slot 133 with contacts 128 removed). In this manner, test unit 110 a allows a diabetic patient to monitor glucose levels. As used herein, “analyte sensor” refers to an independently interpretable signal representing an amount of an analyte present in a fluid sample. Under this definition, one piece of absorbent material having one reagent that is capable of binding to two different analytes at the same time, would be considered two separate “analyte sensors” if two independently interpretable signals are produced, regardless of whether the signal is interpreted using two different lead wires or using one lead wire (e.g., one signal having two frequency spikes that represent the amount of two different analytes present in the fluid sample).
  • Test unit 110 a also advantageously includes a first sealing surface 134 and a second sealing surface 135, configured to restrict entry of moisture into the interior of cartridge 100 via slots 132 and 133, respectively. Test unit 110 a is disposed at the beginning of the order of use of the plurality of test units 110 in cartridge 100 (i.e., on top of the stack of test units 110, see FIG. 1). As such, test unit 110 a serves to protect the plurality of test units 110 from damage caused by moisture and dust. Test unit 110 a can either be a “sacrificial unit,” meaning its sole purpose is to provide a cork/seal to the orifices of cartridge 100, or can optionally include analyte sensors, such as analyte sensor 115 a. Test unit 110 a also preferably includes a sealing surface on its back side to provide a seal at slot 129. It is also contemplated that each of the plurality of test units 110 can include sealing surfaces to protect each subsequent test unit from moisture.
  • While FIG. 3 shows test unit 110 a having a “strip” configuration, those of skill in the art will appreciate that other shapes can be used consistently with the inventive subject matter disclosed herein. For example, test unit 110 a could comprise a capsule or a disk rather than a strip. However, stackable test units are preferred in order to conserve space.
  • FIG. 4 shows a test unit 110 b, which has two analyte sensors 115 b and 116 b. Sensor 115 b is configured to detect glucose, while sensor 116 b is configured to detect fructosamine. Test unit 110 b advantageously provides a means for testing for two analytes using one blood sample (i.e., from a single prick and a single test unit). While FIG. 4 shows sensors 115 b and 116 b in completely non-overlapping positions, it is also contemplated that sensors 115 b and 116 b could be partially overlapping, or even completely overlapping. For example, sensors 115 b and 116 b could comprise one absorbent material and one analyte-binding reagent, wherein the analyte-binding reagent is capable of simultaneously binding with two or more analytes and can produce two “distinct” signals (e.g., one signal with two different detectible frequency spikes, or two different signals representing two distinct analytes). One of skill in the art will also appreciate that additional sensors can be included on test unit 110 b for detecting additional analytes.
  • Test unit 110 a and test unit 110 b are “functionally nonfungible” since unit 110 a tests for glucose while unit 110 b detects glucose and fructosamine. An example of two functionally fungible test units is a first test unit that test for glucose and iron, and a second test unit that tests for glucose and iron.
  • FIG. 5 shows a test unit 110 c, which has two analyte sensors 115 c and 116 c. Sensor 115 c is configured to detect glucose, while calibration sensor 116 c is configured to check the accuracy of an analyte testing device. As such, sensor 115 c is an “operational sensor” and sensor 116 c is a “calibration sensor.” Sensor 116 c has a known concentration of a particular analyte and produces a signal that is expected to result in a known reading on device 600. In this manner, the electronics of device 600 can be checked for accuracy, precision, and consistency.
  • FIG. 6 shows an analyte testing device 600. Device 600 is a glucose meter integrated with a lancing device. Device 600 has an actuator 620 and an internal linkage mechanism (not shown) configured to cock a lancet for drawing blood, partially expose a test unit for contacting with a blood sample, and reading a signal of the test unit. Device 600 also has an internal compartment 610 for loading and storing cartridge 100. Device 600 also preferably has an internal compartment for storing a cartridge of lancets (not shown). One exemplary embodiment of a glucose meter is disclosed in U.S. patent application Ser. No. 13/165,621, which is incorporated herein by reference.
  • Device 600 can further include a docking station and data management software. Acceptable docking stations and data management systems that could be adapted for use within the existing subject matter is described in co-pending patent application having Ser. No. 13/187,360 titled to Shaanan et al. “Analyte Testing System With Docking Station For Data Management” filed on Jul. 20, 2011.
  • FIG. 7 shows a method of using test cartridge 100 and analyte testing device 600, comprising: inserting a lancet cartridge into the device; inserting a test unit cartridge into the device, wherein the test unit cartridge has a plurality of nonfungible test units; operating an actuator on the device, which operates a mechanism that (i) readies a lancing device, (ii) advances the lancet cartridge, and (iii) exposes an analyte sensor of a test unit; deploying the lancing device in order to prick a body part and draw a blood sample; and exposing the analyte sensor to the blood sample; reading an output of the device; ejecting and disposing of the test unit; replacing the lancet cartridge with a refill lancet cartridge; and replacing the test unit cartridge with a refill test unit cartridge. Indicia of the first two and last two steps are displayed in round boxes and with dotted lines to indicate that these steps need not be repeated at every cycle of usage of the device. For example, in embodiments having twenty lancets and test units per cartridge, the steps of inserting/removing cartridges need only be performed every twentieth cycle of use. In addition, the nonfungible test units preferably comprise at least one test unit configured to detect a first and second analyte.
  • In one aspect of some preferred embodiments, the actuator is mechanically advantaged and the step of operating the actuator comprises cocking a lever.
  • As used herein, and unless the context dictates otherwise, the term “coupled to” is intended to include both direct coupling (in which two elements that are coupled to each other contact each other) and indirect coupling (in which at least one additional element is located between the two elements). Therefore, the terms “coupled to” and “coupled with” are used synonymously.
  • It should be apparent to those skilled in the art that many more modifications besides those already described are possible without departing from the inventive concepts herein. The inventive subject matter, therefore, is not to be restricted except in the scope of the appended claims. Moreover, in interpreting both the specification and the claims, all terms should be interpreted in the broadest possible manner consistent with the context. In particular, the terms “comprises” and “comprising” should be interpreted as referring to elements, components, or steps in a non-exclusive manner, indicating that the referenced elements, components, or steps may be present, or utilized, or combined with other elements, components, or steps that are not expressly referenced. Where the specification claims refers to at least one of something selected from the group consisting of A, B, C . . . and N, the text should be interpreted as requiring only one element from the group, not A plus N, or B plus N, etc.

Claims (14)

1. A test unit cartridge comprising:
a first test unit having a first analyte sensor that includes a first reagent used to detect a first analyte; and
a second test unit having a second analyte sensor that includes a second reagent used to detect a second analyte different from the first analyte, such that the first test unit is not functionally fungible with the second test unit, wherein
the first test unit and the second test unit are arranged in a stacked configuration within the test unit cartridge among a plurality test units;
the first test unit is situated at a first position within the stacked configuration and used to detect the first analyte, and
the second test unit is situated at a second position within the stacked configuration and used to detect the second analyte so as to allow detection of the first analyte and the second analyte at a predetermined interval.
2. The cartridge of claim 1, wherein the first test unit comprises a single strip.
3. The cartridge of claim 1, wherein the first test unit has no other analyte sensors besides the first analyte sensor.
4. The cartridge of claim 1, wherein the first test unit contains a third analyte sensor that detects the second analyte.
5. The cartridge of claim 4, wherein the first and third analyte sensors are physically separated by a distance.
6. The cartridge of claim 1, wherein the first test unit is disposed at a beginning of an order of use of the cartridge, and has a sealing surface that cooperates with a housing of the cartridge to restrict entry of moisture into the cartridge.
7. The cartridge of claim 1, further comprising a third through a twentieth test unit, each of which is functionally fungible with one of the first and second test units.
8. The cartridge of claim 1, wherein the second reagent is different from the first reagent.
9. The cartridge of claim 1, further comprising a pull-away label covering an aperture of the cartridge.
10. The cartridge of claim 1, further comprising an aperture disposed on the cartridge such that an electrical contact of the first test unit can directly couple with an electrical contact of an analyte testing device.
11. The cartridge of claim 1, further comprising a calibration test unit.
12. The cartridge of claim 1 further comprising a spring disposed in a manner to advance each test unit into a usable position after a previous test unit has been laterally ejected from the cartridge.
13. (canceled)
14-19. (canceled)
US13/308,137 2011-06-21 2011-11-30 Test unit cartridge for analyte testing device Expired - Fee Related US8333717B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US13/308,137 US8333717B1 (en) 2011-06-21 2011-11-30 Test unit cartridge for analyte testing device
KR1020147001534A KR101596799B1 (en) 2011-06-21 2012-06-21 Test unit cartridge for alalyte testing device
PCT/US2012/043588 WO2012177908A1 (en) 2011-06-21 2012-06-21 Test unit cartridge for analyte testing device
JP2014517176A JP5998212B2 (en) 2011-06-21 2012-06-21 Method of using test unit cartridge and analyte test device
EP12743557.6A EP2723235B1 (en) 2011-06-21 2012-06-21 Test unit cartridge for analyte testing device
CA2839900A CA2839900A1 (en) 2011-06-21 2012-06-21 Test unit cartridge for analyte testing device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/165,621 US20120330119A1 (en) 2011-06-21 2011-06-21 Analyte Testing Device with Lancet Cartridge and Test Strip Cartridge
US13/187,397 US8333716B1 (en) 2011-06-21 2011-07-20 Methods for using an analyte testing device
US13/308,137 US8333717B1 (en) 2011-06-21 2011-11-30 Test unit cartridge for analyte testing device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/187,397 Continuation US8333716B1 (en) 2011-06-21 2011-07-20 Methods for using an analyte testing device

Publications (2)

Publication Number Publication Date
US8333717B1 US8333717B1 (en) 2012-12-18
US20120329164A1 true US20120329164A1 (en) 2012-12-27

Family

ID=47325224

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/187,397 Expired - Fee Related US8333716B1 (en) 2011-06-21 2011-07-20 Methods for using an analyte testing device
US13/308,137 Expired - Fee Related US8333717B1 (en) 2011-06-21 2011-11-30 Test unit cartridge for analyte testing device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13/187,397 Expired - Fee Related US8333716B1 (en) 2011-06-21 2011-07-20 Methods for using an analyte testing device

Country Status (6)

Country Link
US (2) US8333716B1 (en)
EP (1) EP2723235B1 (en)
JP (1) JP5998212B2 (en)
KR (1) KR101596799B1 (en)
CA (1) CA2839900A1 (en)
WO (1) WO2012177908A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160374603A1 (en) * 2014-03-12 2016-12-29 Yofimeter, Llc Analyte testing devices with lancet advancement tracking and color touch screen user interface
US20220139507A1 (en) * 2019-06-19 2022-05-05 Hewlett-Packard Development Company, L.P. Using medical test results to trigger routine for medical supply replenishment

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11320418B2 (en) 2012-12-12 2022-05-03 Iassay, Inc. Modular hand-held point of care testing system
US20140364711A1 (en) * 2013-03-27 2014-12-11 AkibaH Health Corporation All-in-one analyte sensor in a detachable external mobile device case
SG11201508518UA (en) 2013-04-22 2015-11-27 Theranos Inc Methods, devices, and systems for secure transport of materials
EP3061062B1 (en) * 2013-10-24 2022-11-16 Labrador Diagnostics LLC Systems and methods for ordering laboratory tests and providing results thereof
KR101582219B1 (en) * 2014-07-07 2016-01-04 최인상 Biosensor strip dispenser for blood glucose measurement
US10160589B2 (en) 2014-07-07 2018-12-25 In Sang Choi Biosensor strip dispensing apparatus and strip cartridge used by being coupled thereto
KR101582222B1 (en) * 2014-07-07 2016-01-04 최인상 Biosensor strip cartridge
JP6974426B2 (en) * 2016-08-11 2021-12-01 エスアールアイ インターナショナルSRI International Biological sample analysis system, components, and methods thereof
KR101993681B1 (en) * 2017-06-02 2019-06-28 주식회사 아이센스 Strip cartridge for integrated measuring meter of blood glucose
CN108860988A (en) * 2018-07-04 2018-11-23 芜湖圣美孚科技有限公司 A kind of blood glucose meter test paper box structure and take test paper method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999035487A1 (en) * 1998-01-06 1999-07-15 Skyline Venture Partners, L.P. Methods and apparatus for accurate analysis of bodily fluid constituents
US20040082878A1 (en) * 2002-08-14 2004-04-29 Dene Baldwin Oral fluid collection, transfer and transportation device and method
US20050227370A1 (en) * 2004-03-08 2005-10-13 Ramel Urs A Body fluid analyte meter & cartridge system for performing combined general chemical and specific binding assays
US20090050491A1 (en) * 2005-08-05 2009-02-26 Brown Daniel V Method for distinguishing electrochemical sensors
US20100262380A1 (en) * 2008-09-22 2010-10-14 Matievich Jr William Analyte Testing Systems

Family Cites Families (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794926A (en) 1986-11-24 1989-01-03 Invictus, Inc. Lancet cartridge
GB8713810D0 (en) 1987-06-12 1987-07-15 Hypoguard Uk Ltd Measured dose dispensing device
JPH0395440A (en) * 1989-09-08 1991-04-19 Terumo Corp Measuring apparatus
US5064098A (en) 1990-02-23 1991-11-12 Physical Systems, Inc. Dual component dispenser gun
US5196025A (en) 1990-05-21 1993-03-23 Ryder International Corporation Lancet actuator with retractable mechanism
US5322511A (en) 1992-04-21 1994-06-21 Sterling Winthrop Inc. Portable hand-held power injector
US5269762A (en) 1992-04-21 1993-12-14 Sterling Winthrop, Inc. Portable hand-held power assister device
US5536249A (en) 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US5569186A (en) 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5637095A (en) 1995-01-13 1997-06-10 Minimed Inc. Medication infusion pump with flexible drive plunger
EP0840628B1 (en) 1995-06-02 2002-05-08 Novo Nordisk A/S Automatic withdrawal of piston rod
US5674236A (en) 1996-04-30 1997-10-07 Medtronic, Inc. Lancet for capillary puncture blood samples
US6332871B1 (en) 1996-05-17 2001-12-25 Amira Medical Blood and interstitial fluid sampling device
DE19717107B4 (en) 1997-04-23 2005-06-23 Disetronic Licensing Ag System of container and drive device for a piston, which is held in the container containing a drug fluid
US6454746B1 (en) 1997-06-04 2002-09-24 Eli Lilly And Company Medication delivery apparatus
US5971941A (en) 1997-12-04 1999-10-26 Hewlett-Packard Company Integrated system and method for sampling blood and analysis
US5871494A (en) 1997-12-04 1999-02-16 Hewlett-Packard Company Reproducible lancing for sampling blood
US6071294A (en) 1997-12-04 2000-06-06 Agilent Technologies, Inc. Lancet cartridge for sampling blood
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
DE19840856B4 (en) 1998-09-07 2008-04-10 Roche Diagnostics Gmbh System for obtaining a body fluid, lancet magazine, lancet, lancet set, lancing device and method for removing a lancet from a lancet magazine and use of the system
TW453884B (en) 1999-09-16 2001-09-11 Novo Nordisk As Dose setting limiter
JP2003510135A (en) 1999-09-29 2003-03-18 スターリング メディヴェイションズ インコーポレイテッド Reusable pharmaceutical injection device
US6228100B1 (en) 1999-10-25 2001-05-08 Steven Schraga Multi-use lancet device
US6585698B1 (en) 1999-11-01 2003-07-01 Becton, Dickinson & Company Electronic medical delivery pen having a multifunction actuator
US6364889B1 (en) 1999-11-17 2002-04-02 Bayer Corporation Electronic lancing device
US6316264B1 (en) 1999-12-17 2001-11-13 Bayer Corporation Test strip for the assay of an analyte in a liquid sample
TW523415B (en) 2000-03-24 2003-03-11 Novo Nordisk As A flexible piston rod
US6827899B2 (en) 2000-08-30 2004-12-07 Hypoguard Limited Test device
DE10047419A1 (en) 2000-09-26 2002-04-11 Roche Diagnostics Gmbh Lancet system
DE10057832C1 (en) 2000-11-21 2002-02-21 Hartmann Paul Ag Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample
CA2405524A1 (en) 2001-02-08 2002-08-15 Inverness Medical Limited A personal condition management system
GB0107608D0 (en) 2001-03-27 2001-05-16 Dca Design Int Ltd Improvements in and relating to an injection device
GB0107600D0 (en) 2001-03-27 2001-05-16 Dca Design Int Ltd Improvements in and relating to an injection device
CN100339044C (en) * 2001-03-29 2007-09-26 因弗内斯医疗有限公司 Integrated measuring apparatus for testing samples
US6767710B2 (en) 2001-03-30 2004-07-27 Praxsys Biosystems, Llc Prewetting stop flow test strip
US6783502B2 (en) 2001-04-26 2004-08-31 Phoenix Bioscience Integrated lancing and analytic device
DE60214375T2 (en) 2001-05-18 2007-08-30 Polymer Technology Systems, Inc., Indianapolis DEVICE FOR EXAMINING BODY FLUIDS WITH SOLVENTLY FIXED, PORTABLE TEST DEVICE
DE60229988D1 (en) 2001-06-08 2009-01-02 Roche Diagnostics Gmbh Removal device for Körperflussigkeiten
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US6671989B2 (en) 2001-06-18 2004-01-06 Chester Vanek Multi-shot ring airfoil projectile launcher
US6997343B2 (en) 2001-11-14 2006-02-14 Hypoguard Limited Sensor dispensing device
US6872358B2 (en) 2002-01-16 2005-03-29 Lifescan, Inc. Test strip dispenser
US7004928B2 (en) 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
DE20213607U1 (en) 2002-02-21 2003-07-03 Hartmann Paul Ag Blood analyzer for the determination of an analyte
JP3777136B2 (en) 2002-04-01 2006-05-24 インターナショナル・ビジネス・マシーンズ・コーポレーション Computer device, data dead copy method, program, and computer device operating method
GB2388898B (en) * 2002-04-02 2005-10-05 Inverness Medical Ltd Integrated sample testing meter
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2003088824A2 (en) 2002-04-19 2003-10-30 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7192405B2 (en) 2002-09-30 2007-03-20 Becton, Dickinson And Company Integrated lancet and bodily fluid sensor
US7399401B2 (en) 2002-10-09 2008-07-15 Abbott Diabetes Care, Inc. Methods for use in assessing a flow condition of a fluid
WO2004041330A2 (en) 2002-11-05 2004-05-21 M 2 Medical A/S A disposable wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
US6931328B2 (en) 2002-11-08 2005-08-16 Optiscan Biomedical Corp. Analyte detection system with software download capabilities
AU2003291963A1 (en) 2002-12-23 2004-07-14 M 2 Medical A/S Flexible piston rod
EP1583571B1 (en) 2002-12-23 2008-02-13 M2 Medical A/S Medical dispensing device for insulin
US8052926B2 (en) 2002-12-27 2011-11-08 Roche Diagnostics Operations, Inc. Method for manufacturing a sterilized lancet integrated biosensor
US7481777B2 (en) 2006-01-05 2009-01-27 Roche Diagnostics Operations, Inc. Lancet integrated test element tape dispenser
US7815579B2 (en) 2005-03-02 2010-10-19 Roche Diagnostics Operations, Inc. Dynamic integrated lancing test strip with sterility cover
EP1581115B1 (en) 2002-12-30 2009-10-14 Roche Diagnostics GmbH Blood acquisition suspension system
US20040172284A1 (en) 2003-02-13 2004-09-02 Roche Diagnostics Corporation Information management system
GB0304823D0 (en) 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
GB0304824D0 (en) 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
DE10312357B3 (en) 2003-03-20 2004-07-08 Roche Diagnostics Gmbh Pricking aid for needle system for extraction of blood for medical diagnosis enclosing needle with opening for passage of needle point during puncturing of skin
US20060229502A1 (en) 2003-06-03 2006-10-12 Bayer Healthcare Llc Portable medical diagnostic apparatus
RU2005141579A (en) 2003-06-03 2006-05-10 Байер Хелткэр Ллс (Us) PORTABLE MEDICAL DIAGNOSTIC DEVICE
PT1656170T (en) 2003-08-12 2019-05-31 Lilly Co Eli Medication dispensing apparatus with triple screw threads for mechanical advantage
US7223248B2 (en) * 2003-08-13 2007-05-29 Lifescan, Inc. Packaged medical device with a deployable dermal tissue penetration member
JP2007506946A (en) 2003-09-23 2007-03-22 エピネックス・ダイアグノスティクス・インコーポレーテッド Rapid examination of glycoalbumin
WO2005072794A2 (en) 2004-01-29 2005-08-11 M 2 Medical A/S Disposable medicine dispensing device
US20080312555A1 (en) 2004-02-06 2008-12-18 Dirk Boecker Devices and methods for glucose measurement using rechargeable battery energy sources
PT1715904E (en) 2004-02-18 2015-12-22 Ares Trading Sa Hand-held electronically controlled injection device for injecting liquid medications
EP1717942B1 (en) 2004-02-19 2010-10-06 Mitsubishi Denki K.K. Multiple phase simultaneous switching preventing circuit, pwm inverter and its driving method
BRPI0512407A (en) * 2004-06-24 2008-03-04 Bayer Healthcare Llc cartridge and instrument sensor dispenser
US7261691B1 (en) 2004-08-02 2007-08-28 Kwabena Asomani Personalized emergency medical monitoring and transmission system
US20100096399A1 (en) 2004-12-11 2010-04-22 Novation Science Holding, Llc Smart Medicine Container
US7935063B2 (en) 2005-03-02 2011-05-03 Roche Diagnostics Operations, Inc. System and method for breaking a sterility seal to engage a lancet
WO2006105792A1 (en) 2005-04-06 2006-10-12 M 2 Medical A/S Method and device for dispensing liquid medicine by means of a reversible electrical motor
US20060245131A1 (en) 2005-04-29 2006-11-02 Ramey Blaine E Electrical protection circuitry for a docking station base of a hand held meter and method thereof
EP1891561B1 (en) 2005-05-17 2020-01-15 F. Hoffmann-La Roche AG Host apparatus and method providing calibration and reagent information to a measurement apparatus which makes use of a consumable reagent in a measuring process
EP1726950A1 (en) 2005-05-24 2006-11-29 F. Hoffmann-La Roche Ag Cartridge for storing test elements
US7848765B2 (en) 2005-05-27 2010-12-07 Where, Inc. Location-based services
WO2006133435A2 (en) 2005-06-08 2006-12-14 Agamatrix, Inc Data collection system and interface
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
AR057484A1 (en) 2005-08-04 2007-12-05 Bayer Healthcare Llc SMALL PUNCTURE DEVICE
US20070073590A1 (en) 2005-08-22 2007-03-29 Cosentino Louis C Remote monitor for physiological parameters and durable medical supplies
US8105279B2 (en) 2005-09-26 2012-01-31 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US7534226B2 (en) 2005-09-26 2009-05-19 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US8057436B2 (en) 2005-09-26 2011-11-15 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
US7794427B2 (en) 2005-09-26 2010-09-14 Asante Solutions, Inc. Operating an infusion pump system
EP1928304B1 (en) 2005-09-30 2012-10-24 Intuity Medical, Inc. Catalysts for body fluid sample extraction
WO2007047279A1 (en) 2005-10-18 2007-04-26 Richards Cynthia C Dispenser having a first pump for insulin and a second pump for glucose or glucagon
NZ568489A (en) 2005-10-24 2011-08-26 Manawatu Diagnostics Ltd Ovulation cycle monitoring and management
EP3064236B1 (en) 2005-11-08 2020-02-05 Bigfoot Biomedical, Inc. Method and system for manual and autonomous control of an infusion pump
US20080200838A1 (en) 2005-11-28 2008-08-21 Daniel Goldberger Wearable, programmable automated blood testing system
US8815175B2 (en) 2005-11-30 2014-08-26 Abbott Diabetes Care Inc. Integrated meter for analyzing biological samples
US7922971B2 (en) 2005-11-30 2011-04-12 Abbott Diabetes Care Inc. Integrated meter for analyzing biological samples
WO2007081853A2 (en) 2006-01-05 2007-07-19 University Of Virginia Patent Foundation Method, system and computer program product for evaluation of blood glucose variability in diabetes from self-monitoring data
US7811430B2 (en) 2006-02-28 2010-10-12 Abbott Diabetes Care Inc. Biosensors and methods of making
WO2007112034A2 (en) 2006-03-23 2007-10-04 Becton, Dickinson And Company System and methods for improved diabetes data management and use
US7887682B2 (en) 2006-03-29 2011-02-15 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7662065B1 (en) 2006-09-01 2010-02-16 Dp Technologies, Inc. Method and apparatus to provide daily goals in accordance with historical data
EP1923085A1 (en) 2006-11-17 2008-05-21 Sanofi-Aventis Deutschland GmbH Dosing and drive mechanism for drug delivery device
US20080139910A1 (en) 2006-12-06 2008-06-12 Metronic Minimed, Inc. Analyte sensor and method of using the same
WO2008082987A2 (en) 2006-12-26 2008-07-10 Abbott Diabetes Care Inc Analyte meter protectors and methods
US7981102B2 (en) 2007-05-21 2011-07-19 Asante Solutions, Inc. Removable controller for an infusion pump
US7892199B2 (en) 2007-05-21 2011-02-22 Asante Solutions, Inc. Occlusion sensing for an infusion pump
US7794426B2 (en) 2007-05-21 2010-09-14 Asante Solutions, Inc. Infusion pump system with contamination-resistant features
US7833196B2 (en) 2007-05-21 2010-11-16 Asante Solutions, Inc. Illumination instrument for an infusion pump
US20090138207A1 (en) 2007-05-24 2009-05-28 Cosentino Daniel L Glucose meter system and monitor
DE602008006748D1 (en) * 2007-08-29 2011-06-16 Brighter Ab PORTABLE MEDICAL DEVICE WITH SAMPLE DETERGENT, DETERGENT AND INJECTION AGENT
US7717903B2 (en) 2007-09-06 2010-05-18 M2 Group Holdings, Inc. Operating an infusion pump system
US7828528B2 (en) 2007-09-06 2010-11-09 Asante Solutions, Inc. Occlusion sensing system for infusion pumps
US7879026B2 (en) 2007-09-07 2011-02-01 Asante Solutions, Inc. Controlled adjustment of medicine dispensation from an infusion pump device
US7935105B2 (en) 2007-09-07 2011-05-03 Asante Solutions, Inc. Data storage for an infusion pump system
US7935076B2 (en) 2007-09-07 2011-05-03 Asante Solutions, Inc. Activity sensing techniques for an infusion pump system
US20110124130A1 (en) 2008-04-03 2011-05-26 Peter Wagner Device and method for analysis of samples with depletion of analyte content
US20090322513A1 (en) 2008-06-27 2009-12-31 Franklin Dun-Jen Hwang Medical emergency alert system and method
US8282578B2 (en) 2008-10-03 2012-10-09 Abbott Diabetes Care Inc. Integrated lancet and analyte testing apparatus
WO2010049669A1 (en) 2008-10-27 2010-05-06 Lifescan Scotland Limited Methods and devices for mitigating esd events
JP2012513626A (en) 2008-12-23 2012-06-14 エフ.ホフマン−ラ ロシュ アーゲー Management method and system for implementation, execution, data collection, and data analysis of structured collection procedures operating on a collection device
US9375529B2 (en) 2009-09-02 2016-06-28 Becton, Dickinson And Company Extended use medical device
US8753290B2 (en) * 2009-03-27 2014-06-17 Intellectual Inspiration, Llc Fluid transfer system and method
US20100249652A1 (en) 2009-03-31 2010-09-30 Abbott Diabetes Care Inc. Integrated Analyte Devices and Processes
US8758583B2 (en) 2009-04-28 2014-06-24 Abbott Diabetes Care Inc. Smart sensor ports and methods of using same
US20100295674A1 (en) 2009-05-21 2010-11-25 Silverplus, Inc. Integrated health management console
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
CA2957078C (en) 2009-06-30 2019-04-30 Lifescan, Inc Analyte testing methods and device for calculating basal insulin therapy
EP2284747A1 (en) 2009-08-12 2011-02-16 F. Hoffmann-La Roche AG Method of recording data for keeping diary of a medical testing or therapy
US20110040165A1 (en) 2009-08-13 2011-02-17 Williams Iii George M Integrated cartridge and tub assembly
ES2912584T3 (en) 2009-08-31 2022-05-26 Abbott Diabetes Care Inc A glucose monitoring system and method
US20110124996A1 (en) 2009-11-20 2011-05-26 Roche Diagnostics Operations, Inc. Diabetes health management systems and methods

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999035487A1 (en) * 1998-01-06 1999-07-15 Skyline Venture Partners, L.P. Methods and apparatus for accurate analysis of bodily fluid constituents
US20040082878A1 (en) * 2002-08-14 2004-04-29 Dene Baldwin Oral fluid collection, transfer and transportation device and method
US20050227370A1 (en) * 2004-03-08 2005-10-13 Ramel Urs A Body fluid analyte meter & cartridge system for performing combined general chemical and specific binding assays
US20090050491A1 (en) * 2005-08-05 2009-02-26 Brown Daniel V Method for distinguishing electrochemical sensors
US20100262380A1 (en) * 2008-09-22 2010-10-14 Matievich Jr William Analyte Testing Systems

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160374603A1 (en) * 2014-03-12 2016-12-29 Yofimeter, Llc Analyte testing devices with lancet advancement tracking and color touch screen user interface
US20220139507A1 (en) * 2019-06-19 2022-05-05 Hewlett-Packard Development Company, L.P. Using medical test results to trigger routine for medical supply replenishment

Also Published As

Publication number Publication date
EP2723235A1 (en) 2014-04-30
US20120329083A1 (en) 2012-12-27
EP2723235B1 (en) 2015-11-25
JP2014522677A (en) 2014-09-08
WO2012177908A1 (en) 2012-12-27
JP5998212B2 (en) 2016-09-28
US8333717B1 (en) 2012-12-18
CA2839900A1 (en) 2012-12-27
KR20140042870A (en) 2014-04-07
US8333716B1 (en) 2012-12-18
KR101596799B1 (en) 2016-02-24

Similar Documents

Publication Publication Date Title
US8333717B1 (en) Test unit cartridge for analyte testing device
US8337423B2 (en) Blood glucose sensor
EP1869456B1 (en) Sensor-dispensing instruments
US7771367B2 (en) Lancet wheel
EP2856155B1 (en) Multistrip cartridge
US7749174B2 (en) Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
EP1578271B1 (en) Body fluid testing device
EP2723234B1 (en) Analyte testing device with lancet cartridge and test strip cartridge
IL155344A (en) Minimal procedure analyte test system
US8172866B2 (en) Medical aid
JP2008113770A (en) Biosensor cartridge

Legal Events

Date Code Title Description
AS Assignment

Owner name: GADLIGHT, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHAANAN, GAD;GOLDMAN, MARC;REEL/FRAME:027301/0018

Effective date: 20110720

AS Assignment

Owner name: YOFIMETER, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GADLIGHT, INC.;REEL/FRAME:028080/0570

Effective date: 20120322

AS Assignment

Owner name: YOFIMETER, LLC, CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S BUSINESS ENTITY DESIGNATION FROM "INC." TO "LLC" PREVIOUSLY RECORDED ON REEL 028080 FRAME 0570. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE'S CORRECT BUSINESS NAME AND ENTITY IS YOFIMETER, LLC;ASSIGNOR:GADLIGHT, INC.;REEL/FRAME:028840/0796

Effective date: 20120322

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20201218